Description of Patients Undergoing Mohs Surgery in Spain: Initial Report on Data From the Spanish Registry of Mohs Surgery (REGESMOHS)
Ruiz-Salas V(1), Garcés JR(2), Miñano Medrano R(3), Alonso-Alonso T(4), Rodríguez-Prieto MÁ(4), López-Estebaranz JL(3), Sanmartín-Jiménez O(5), Guillén Barona C(5), Delgado Jiménez Y(6), Toll-Abelló A(7), Vargas Diez E(8), Ciudad Blanco C(9), Alfaro Rubio A(10), Allende Markixana I(11), de Eusebio Murillo E(12), Manubens-Mercadé E(13), Vázquez-Veiga H(14), Barchino Ortiz L(9), García-Doval I(15), Redondo Bellón P(16). (1) Hospital de la Santa Creu i Sant Pau, Barcelona, España.
(2) Hospital de la Santa Creu i Sant Pau, Barcelona, España; Hospital Quirón Teknon, Barcelona, España.
(3) Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España.
(4) Complejo Asistencial Universitario de León, León, España.
(5) Instituto Valenciano de Oncología, Valencia, España.
(6) Clínica Quirón, Madrid, España; Hospital de La Princesa, Madrid, España.
(7) Hospital del Mar, Barcelona, España.
(8) Hospital de La Princesa, Madrid, España.
(9) Hospital La Zarzuela, Madrid, España; Hospital Gregorio Marañón, Madrid, España.
(10) Hospital de Manises, Manises, Valencia, España.
(11) Hospital Universitario de Cruces, Barakaldo, Vizcaya, España.
(12) Complejo Hospitalario Universitario de Guadalajara, Guadalajara, España.
(13) Hospital Quirón Teknon, Barcelona, España.
(14) Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, A Coruña, España.
(15) Unidad de Investigación, Fundación Academia Española de Dermatología, Madrid, España.
(16) Clínica Universitaria de Navarra, Pamplona, Navarra, España.
The Spanish registry of Mohs micrographic surgery started collecting data in July 2013. The aim of the registry is to report on the use of this technique in Spain and the outcomes achieved. In the present article, we describe the characteristics of patients and the tumors treated.
MATERIAL AND METHODS:
This is a prospective cohort study of patients treated with Mohs micrographic surgery. The participating centers are hospitals where at least one intervention of this type is performed each week. All patients considered for Mohs micrographic surgery in participating centers are included in the registry except those who have been declared legally incompetent.
Between July 2013 and October 2014, data from 655 patients were included in the registry. The most common tumor involved was basal cell carcinoma, and the most common histological subtype was infiltrative basal cell carcinoma. Most of the tumors treated were located on the face or scalp, and the most common site was the nose. Almost 40% of the tumors treated were recurrent or persistent, and preoperative tumor size was similar to that reported in other European studies and in Australia. In total, 45.5% of patients had received previous surgical treatment.
The findings are similar to those reported in other studies, and the data collected are useful for assessing whether the results of studies carried out elsewhere are applicable in Spain.
CITATION Actas Dermosifiliogr. 2015 May 28. pii: S0001-7310(15)00168-4. doi: 10.1016/j.ad.2015.04.002.